196 related articles for article (PubMed ID: 11148482)
1. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Yanase DJ; David-Bajar K
J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
3. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
Broshtilova V; Gantcheva M
Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
[TBL] [Abstract][Full Text] [Related]
5. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
7. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
Lehtimäki L; Petäys T; Haahtela T
Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
Capella GL; Grigerio E; Altomare G
Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
[TBL] [Abstract][Full Text] [Related]
10. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Angelova-Fischer I; Tsankov N
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
[TBL] [Abstract][Full Text] [Related]
12. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
[TBL] [Abstract][Full Text] [Related]
13. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
14. Montelukast treatment in children with moderately severe atopic dermatitis.
Ehlayel MS; Bener A; Sabbah A
Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: a prospective, double-blind, randomized, placebo-controlled study.
Fujiwara H; Konno R; Netsu S; Odagiri K; Taneichi A; Takamizawa S; Ohwada M; Suzuki M
Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):195-8. PubMed ID: 19944517
[TBL] [Abstract][Full Text] [Related]
16. [A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients].
Concha del Río LE; Arroyave CM
Rev Alerg Mex; 2003; 50(5):187-91. PubMed ID: 14631590
[TBL] [Abstract][Full Text] [Related]
17. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
18. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
Warner JO;
J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
[TBL] [Abstract][Full Text] [Related]
19. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
